Ventura Securities has initiated coverage on Jubilant Pharmova Ltd with a "BUY" recommendation at the current market price of Rs 1,067, assigning a 24-month price target of Rs 1,557, representing a

Shares of Jubilant Pharmova surged nearly 9% on September 9, hitting a record high of ₹1,038 after the company posted strong quarterly earnings and issued positive guidance.

Ace investor Rakesh Jhunjhunwala has bought 25 lakh shares in Jubilant Pharmova and his wife Rekha Jhunjhunwala bought 20 lakh shares.